Teladoc Health, Inc. (TDOC) Stock Slumping in Pre-Market, Here’s the Reason

Teladoc Health, Inc. (TDOC), a virtual healthcare services provider, has declined 1.23% in the premarket trading session. As a result, the stock is trading at $64.50 at the time of the writing. During Tuesday’s mid-day session, the stock slightly increased by 046% and closed the day at $65.30. The stock went into decline in the aftermarket as soon as the company announced financial results.

Q4 and FY 2021 Results

On Tuesday, TDOC reported the results for Q4 and FY 2021, which ended 31st December 2021. The company generated revenue of $554.2 million during the quarter, an increase of 45% on a year-over-year basis. The net loss for the three months was $11 million (or $0.07 per share) compared to $394 million (or $3.07 per share) for Q4 2020. During the fiscal year 2021, the total revenue generated by the company was $2.03 billion, an increase of 86% compared to fiscal 2020. The net loss for the year was $428.8 million (or $2.73 per share) compared to $485 million (or $5.36 per share) for fiscal 2020.

TDOC Q1 and FY 2022 Financial Outlook

Alongside the financial results, TDOC also reported the financial outlook for Q1 and FY 2022. For the first quarter of the fiscal year 2022, the company expects revenue in a range of $565 to $571 million, while the net loss per share is expected to remain between $0.60 and $0.50 per share. For the full year 2022, the company expects revenue in a range of $2.55 to $2.65 billion, while the net loss per share is expected to remain between $1.60 and $1.40 per share.

Executive Commentary

While commenting on the results, Jason Gorevic, CEO of TDOC, said that the company has taken a giant stride toward achieving its goals during the fiscal year 2021. The company is quite excited about 2022. It hopes that it would continue to expand in new markets and deepen its relationship with the clients during 2022.

What’s Ahead for TDOC?

Analysts believe that the stock currently holds several negative signals. Hence, it is expected to perform poorly in the next couple of weeks. Hence, TDOC stock holds a negative evaluation at the moment. Investors should take a careful decision regarding investment in TDOC stock.